PFTK1 promotes gastric cancer progression by regulating proliferation, migration and invasion

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Yang, Lei ^a   Zhu, Jia ^a   Huang, Hua ^b   Yang, Qichang ^c   Cai, Jing ^a   Wang, Qiuhong ^a   Zhu, Junya ^b   Shao, Mengting ^b   Xiao, Jinzhang ^a   Cao, Jie ^c   Gu, Xiaodan ^b   Zhang, Shusen ^b   Wang, Yingying ^b  

^a NANTONG TUMOR HOSPITAL   (China)

^b NANTONG UNIVERSITY   (China)

^c Nantong First People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 1; PROTEIN PFTK1; UNCLASSIFIED DRUG; CDK14 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; STOMACH CANCER; TUMOR INVASION; UPREGULATION; BIOSYNTHESIS; CELL MOTION; DISEASE COURSE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RNA INTERFERENCE; STOMACH; STOMACH TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH; STOMACH NEOPLASMS;

EID: 84949513940     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140451     Document Type: Article

References (28)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: a cancer journal for clinicians. 2014; 64 (1):9-29.
2. Wang J, Yu JC, Kang WM, Ma ZQ. Treatment strategy for early gastric cancer. Surgical oncology. 2012; 21(2):119-23. doi: 10.1016/j.suronc.2010.12.004 PMID: 21256735
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: a cancer journal for clinicians. 2011; 61(2):69-90.
4. Cao Y, DePinho RA, Ernst M, Vousden K. Cancer research: past, present and future. Nature reviews Cancer. 2011; 11(10):749-54. doi: 10.1038/nrc3138 PMID: 21918542
5. Malumbres M, Harlow E, Hunt T, Hunter T, Lahti JM, Manning G, et al. Cyclin-dependent kinases: a family portrait. Nature cell biology. 2009; 11(11):1275-6. doi: 10.1038/ncb1109-1275 PMID: 19884882
6. Lazzaro MA, Julien JP. Chromosomal mapping of the PFTAIRE gene, Pftk1, a cdc2-related kinase expressed predominantly in the mouse nervous system. Genomics. 1997; 42(3):536-7. PMID: 9205131
7. Yang T, Chen JY. Identification and cellular localization of human PFTAIRE1. Gene. 2001; 267(2):165-72. PMID: 11313143
8. Jiang M, Gao Y, Yang T, Zhu X, Chen J. Cyclin Y, a novel membrane-associated cyclin, interacts with PFTK1. FEBS letters. 2009; 583(13):2171-8. doi: 10.1016/j.febslet.2009.06.010 PMID: 19524571
9. Pang EY, Bai AH, To KF, Sy SM, Wong NL, Lai PB, et al. Identification of PFTAIRE protein kinase 1, a novel cell division cycle-2 related gene, in the motile phenotype of hepatocellular carcinoma cells. Hepatology. 2007; 46(2):436-45. PMID: 17559150
10. Shu F, Lv S, Qin Y, Ma X, Wang X, Peng X, et al. Functional characterization of human PFTK1 as a cyclin-dependent kinase. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(22):9248-53. PMID: 17517622
11. Xu Y, Wang Z, Wang J, Li J, Wang H, Yue W. Lentivirus-mediated knockdown of cyclin Y (CCNY) inhibits glioma cell proliferation. Oncology research. 2010; 18(8):359-64. PMID: 20441050
12. Kaldis P, Pagano M. Wnt signaling in mitosis. Developmental cell. 2009; 17(6):749-50. doi: 10.1016/j. devcel.2009.12.001 PMID: 20059944
13. Yang HJ, Wang L, Wang M, Ma SP, Cheng BF, Li ZC, et al. Serine/threonine-protein kinase PFTK1 modulates oligodendrocyte differentiation via PI3K/AKT pathway. Journal of molecular neuroscience: MN. 2015; 55(4):977-84. doi: 10.1007/s12031-014-0454-9 PMID: 25355490
14. Leung WK, Ching AK, Chan AW, Poon TC, Mian H, Wong AS, et al. A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility. Oncogene. 2011; 30(44):4464-75. doi: 10.1038/onc.2011.161 PMID: 21577206
15. Mayanagi T, Sobue K. Diversification of caldesmon-linked actin cytoskeleton in cell motility. Cell adhesion & migration. 2011; 5(2):150-9. PMID: 21350330
16. Leung WK, Ching AK, Wong N. Phosphorylation of Caldesmon by PFTAIRE1 kinase promotes actin binding and formation of stress fibers. Molecular and cellular biochemistry. 2011; 350(1-2):201-6. doi: 10.1007/s11010-010-0699-8 PMID: 21184254
17. Sun T, Co NN, Wong N. PFTK1 interacts with cyclin Y to activate non-canonical Wnt signaling in hepatocellular carcinoma. Biochemical and biophysical research communications. 2014; 449(1):163-8. doi: 10.1016/j.bbrc.2014.05.002 PMID: 24824184
18. Liu Y, Chen Y, Lu X, Wang Y, Duan Y, Cheng C, et al. SCYL1BP1 modulates neurite outgrowth and regeneration by regulating the Mdm2/p53 pathway. Molecular biology of the cell. 2012; 23(23):4506-14. doi: 10.1091/mbc.E12-05-0362 PMID: 23051735
19. Ji Y, Tao T, Cheng C, Yang H, Wang Y, Yang J, et al. SSeCKS is a suppressor in Schwann cell differentiation and myelination. Neurochemical research. 2010; 35(2):219-26. doi: 10.1007/s11064-009-0045-2 PMID: 19757038
20. Zhang D, Sun L, Zhu H, Wang L, Wu W, Xie J, et al. Microglial LOX-1 reacts with extracellular HSP60 to bridge neuroinflammation and neurotoxicity. Neurochemistry international. 2012; 61(7):1021-35. doi: 10.1016/j.neuint.2012.07.019 PMID: 22847064
21. Milne AN, Carneiro F, O'Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Human genetics. 2009; 126(5):615-28. doi: 10.1007/s00439-009-0722-x PMID: 19657673
22. Williams GH, Stoeber K. The cell cycle and cancer. The Journal of pathology. 2012; 226(2):352-64. doi: 10.1002/path.3022 PMID: 21990031
23. Besset V, Rhee K, Wolgemuth DJ. The identification and characterization of expression of Pftaire-1, a novel Cdk family member, suggest its function in the mouse testis and nervous system. Molecular reproduction and development. 1998; 50(1):18-29. PMID: 9547506
24. Miyagaki H, Yamasaki M, Miyata H, Takahashi T, Kurokawa Y, Nakajima K, et al. Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma. British journal of cancer. 2012; 106(5):947-54. doi: 10.1038/bjc.2012.35 PMID: 22333595
25. Bani-Hani KE, Almasri NM, Khader YS, Sheyab FM, Karam HN. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2005; 11(4):1447-53.
26. Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nature reviews Cancer. 2008; 8(5):387-98. doi: 10.1038/nrc2389 PMID: 18432252
27. Katoh M. WNT/PCP signaling pathway and human cancer (review). Oncology reports. 2005; 14 (6):1583-8. PMID: 16273260
28. Kurayoshi M, Oue N, Yamamoto H, Kishida M, Inoue A, Asahara T, et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer research. 2006; 66(21):10439-48. PMID: 17079465